Draxxin Rx, 100mg x 100 ml

DRAXXIN™ (tulathromycin) Injectable Solution is a unique, novel treatment that delivers:

• Superior efficacy to treat bovine respiratory disease (BRD).1,2,3
• Convenient, full course of therapy in a single dose.
• Effectiveness against the three major BRD pathogens.
• Mannheimia (Pasteurella) haemolytica
• Pasteurella multocida
• Histophilus somni (Haemophilus somnus)
• Excellent first BRD treatment response.1,2,3
• Remarkably lower mortalities and chronics due to BRD.1,2,3
• Effective control of BRD in cattle at high risk of developing BRD.3

DRAXXIN, tulathromycin, is the first entry of a novel macrolide subclass, the triamilides, developed by Pfizer Animal Health. DRAXXIN is now the first-line product-of-choice to treat BRD, offering both superior disease treatment as well as outstanding efficacy for the control of BRD in cattle at high risk of developing the disease.

A single, subcutaneous injection of 1.1 mL/100 lb. (2.5 mg/kg) of bodyweight delivers a full course of therapy, thereby minimizing labor and handling stress.

Significantly less force was required to expel DRAXXIN through a 10-mL plastic syringe with an 18-gauge, 1.5-inch needle, compared to Nuflor or Micotil.

• Convenient, low dose volume (1 mL/40 kg, or 1.1 mL/100 lb, 100 mg of tulathromycin/mL) and easily syringeable.
• Single dose SC (under the skin) injection in the neck of cattle.
• Packaged in 100, 250 and 500 mL glass vials.
• Ready-to-use, clear aqueous solution.
• Highly syringeable.

Prescription items are NON-RETURNABLE and NON-REFUNDABLE.